105 CMR 164.572
Assessment
(A) Licensed or Approved Providers that directly provide services shall complete an assessment
for each patient and resident that includes the following elements, as well as applicable elements
prescribed for each applicable level or levels of service provided pursuant to 105 CMR 164.100
through 164.400: Part Two:
A history of the use of alcohol, tobacco and other drugs, including age of onset,
duration, patterns and consequences of use; history of overdose, including witnessing an
overdose; use of alcohol, tobacco and other drugs by family members; and types of and
responses to previous treatment.
An assessment of the patient's or resident's psychological, social, health, economic,
educational/ vocational status; co-occurring mental health and/or physical health conditions;
trauma history; and history of compulsive behaviors such as gambling. The assessment must
be completed before a comprehensive service plan is developed for the patient.
(B) Patient or resident treatment may begin prior to completing the assessment, provided that
sufficient information to initiate treatment for the presenting complaint or problem on that day
of services is obtained and that the assessment is completed in a reasonable timeframe.
(C) When the assessments indicates a need for further evaluation, the program shall conduct
necessary testing, physical examination and/or consultation by qualified professionals, or make
appropriate referrals for such testing, physical examination and/or consultation by qualified
professionals, provided the program continues to provide treatment to the patient or resident in
the interim.
(D)
The assessment shall be reviewed and signed by a Senior Clinician, Clinician, or
Practitioner. If conducted by a Clinician, it must be approved in writing by a Senior Clinician
or Practitioner.
(E) The assessment shall conclude with:
(1) a diagnosis of the status and nature of the patient's or resident's substance use disorder,
using standardized definitions established by the American Psychiatric Association, or a
mental or behavioral disorder due to use of psychoactive substances, as defined by the World
Health Organization; and
(2) an offer to the patient or resident to initiate any FDA-approved medication for addiction
treatment.